262 related articles for article (PubMed ID: 31257974)
1. Choroidal Changes at the Leakage Site in Acute Central Serous Chorioretinopathy.
Sahoo NK; Maltsev DS; Goud A; Kulikov AN; Chhablani J
Semin Ophthalmol; 2019; 34(5):380-385. PubMed ID: 31257974
[No Abstract] [Full Text] [Related]
2. SUBFOVEAL CHOROIDAL THICKNESS AND VASCULAR DIAMETER IN ACTIVE AND RESOLVED CENTRAL SEROUS CHORIORETINOPATHY.
Chung YR; Kim JW; Choi SY; Park SW; Kim JH; Lee K
Retina; 2018 Jan; 38(1):102-107. PubMed ID: 28106708
[TBL] [Abstract][Full Text] [Related]
3. PATTERNS OF CHORIOCAPILLARIS FLOW SIGNAL VOIDS IN CENTRAL SEROUS CHORIORETINOPATHY: An Optical Coherence Tomography Angiography Study.
Matet A; Daruich A; Hardy S; Behar-Cohen F
Retina; 2019 Nov; 39(11):2178-2188. PubMed ID: 30028410
[TBL] [Abstract][Full Text] [Related]
4. Low incidence of pachydrusen in central serous chorioretinopathy in an Indian cohort.
Singh SR; Chakurkar R; Goud A; Chhablani J
Indian J Ophthalmol; 2020 Jan; 68(1):118-122. PubMed ID: 31856486
[TBL] [Abstract][Full Text] [Related]
5. Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.
Demirok G; Kocamaz F; Topalak Y; Altay Y; Sengun A
Int Ophthalmol; 2017 Apr; 37(2):409-416. PubMed ID: 27324370
[TBL] [Abstract][Full Text] [Related]
6. Choroidal thickness measurements during central serous chorioretinopathy treatment.
Brandl C; Helbig H; Gamulescu MA
Int Ophthalmol; 2014 Feb; 34(1):7-13. PubMed ID: 23572440
[TBL] [Abstract][Full Text] [Related]
7. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T
Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850
[TBL] [Abstract][Full Text] [Related]
8. Choroidal thickness changes in non-treated acute and ranibizumab-treated chronic central serous chorioretinopathy.
Yumusak E; Gokcinar NB; Ornek K
Medicine (Baltimore); 2018 Oct; 97(43):e12885. PubMed ID: 30412084
[TBL] [Abstract][Full Text] [Related]
9. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N
Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082
[TBL] [Abstract][Full Text] [Related]
10. ASSOCIATION OF OBSTRUCTIVE SLEEP APNEA WITH CENTRAL SEROUS CHORIORETINOPATHY AND CHOROIDAL THICKNESS: A Systematic Review and Meta-Analysis.
Wu CY; Riangwiwat T; Rattanawong P; Nesmith BLW; Deobhakta A
Retina; 2018 Sep; 38(9):1642-1651. PubMed ID: 29474303
[TBL] [Abstract][Full Text] [Related]
11. Choroidal thickness in central serous chorioretinopathy.
Kuroda S; Ikuno Y; Yasuno Y; Nakai K; Usui S; Sawa M; Tsujikawa M; Gomi F; Nishida K
Retina; 2013 Feb; 33(2):302-8. PubMed ID: 23064424
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of fundus fluorescein angiography, indocyanine green angiography and choroidal thickness in central serous chorioretinopathy].
Li L; Li DH; Yang ZK; Bian AL; Chen YX; Dong FT
Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):878-82. PubMed ID: 23302240
[TBL] [Abstract][Full Text] [Related]
13. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy.
Pryds A; Larsen M
Acta Ophthalmol; 2012 Dec; 90(8):738-43. PubMed ID: 21586096
[TBL] [Abstract][Full Text] [Related]
14. Retinal vessels functionality in eyes with central serous chorioretinopathy.
Tomasso L; Benatti L; Rabiolo A; Carnevali A; Zucchiatti I; Querques L; Bandello F; Querques G
Br J Ophthalmol; 2018 Feb; 102(2):210-214. PubMed ID: 28600300
[TBL] [Abstract][Full Text] [Related]
15. Regression patterns of central serous chorioretinopathy using en face optical coherence tomography.
Arora S; Rosario B; Mohammed AR; Beale O; Selvam A; Venkatesh R; Maltsev DS; Chhablani J;
Graefes Arch Clin Exp Ophthalmol; 2022 Aug; 260(8):2475-2481. PubMed ID: 35357548
[TBL] [Abstract][Full Text] [Related]
16. [Changes of choroidal thickness in central serous chorioretinopathy].
Yang LH; Tian B; Shi XH; Ding N; Zhou D; Wei WB
Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):874-7. PubMed ID: 23302239
[TBL] [Abstract][Full Text] [Related]
17. ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration.
Daruich A; Matet A; Marchionno L; De Azevedo JD; Ambresin A; Mantel I; Behar-Cohen F
Retina; 2017 Oct; 37(10):1905-1915. PubMed ID: 28067724
[TBL] [Abstract][Full Text] [Related]
18. Wide-field spectral domain-optical coherence tomography in central serous chorioretinopathy.
Carrai P; Pichi F; Bonsignore F; Ciardella AP; Nucci P
Int Ophthalmol; 2015 Apr; 35(2):167-71. PubMed ID: 25552349
[TBL] [Abstract][Full Text] [Related]
19. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Ojima A; Ogasawara M; Spaide RF
Ophthalmology; 2010 Sep; 117(9):1792-9. PubMed ID: 20472289
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of central serous chorioretinopathy complicated by focal choroidal excavation.
Suzuki M; Gomi F; Hara C; Sawa M; Nishida K
Retina; 2014 Jun; 34(6):1216-22. PubMed ID: 24240563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
